📰 Phase News
Page 1489 - Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Phase. Real-time updates on events, politics, business and more.
February 18, 2021
(Business in Cameroon) - The Cameroonian Head of State, Paul Biya, recently empowered Minister of Economy, Alamine Ousmane Mey to sign, on behalf of Cameroon, a XAF88.8 billion credit agreement with Standard Chartered Bank London and UK Export Finance (Ukef). According to the presidential decree published in that regard, the loan will fund phase 2 of the project aimed at reconstructing the East entrance to Douala. During the said phase, the roadway at the entrance of the Cameroonian economic ...
February 18, 2021
DGAP-News: Immun ... DGAP-News: Immunic, Inc. Announces Positive Top-Line Data From Investigator-Sponsored Phase 2 Proof-of-Concept Clinical Trial of IMU-838 in Primary Sclerosing Cholangitis vom 18.02.2021, 12:30 Uhr Bild: pixabay.com DGAP-News: Immunic, Inc. / Key word(s): Study results Immunic, Inc. Announces Positive Top-Line Data From Investigator-Sponsored Phase 2 Proof-of-Concept Clinical Trial of IMU-838 in Primary Sclerosing Cholangitis 18.02.2021 / 12:30 The issuer is solel...
February 17, 2021
Tennessee will expand vaccine eligibility statewide to residents 65 and older and those in phase 1b of the state’s coronavirus vaccination plan beginning Monday.
February 17, 2021
(2) OCALA, Fla., Feb. 16, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has received approval from the required Ethics Committee in the Netherlands to commence its Phase 1 clinical study on the safety of AIMs drug Ampligen as an intranasal therapy, a critical step in the companys ongoing efforts to develop Ampligen as a potential prophylaxis or treatment for COVID-19 and other respiratory viral diseases. Earlier this year, the company announcedthat ...
February 17, 2021
LONDON (dpa-AFX) - AstraZeneca PLC (AZN.L, AZN) said the OlympiA phase III trial for AstraZeneca and MSD's Lynparza will move to early primary analysis and reporting following a recommendation
February 17, 2021
DGAP-News: Immunic, Inc. Announces That Oral Treatment IMU-838 Shows Evidence of Clinical Activity in Moderate COVID-19 in Phase 2 CALVID-1 Trial Table: IMU-838 Shows Acceleration of Time to Clinical Improvement High-risk patients and patients aged over 65 years experienced a more substantial treatment benefit from IMU-838 than in the general patient population: - The 75% probability [5] to reach clinical improvement (based on investigator assessment) was accelerated by 3.8 days in IMU-838 trea...
February 17, 2021
CASPER, Wyo. (AP) — The Wyoming Department of Health has warned residents about phone...
February 17, 2021
(MENAFN)On Wednesday, Indonesia started the second phase of its vaccination campaign. The government plans to vaccinate 16.9 million public sector workers and 21.5 million people aged over 60 by May. The new phase initiated with Vice President Maâruf Amin, took his first dose of the Chinese Sinovac jab in the capital Jakarta and traders being immunized at the Tanah Abang market, the busiest textile hub in Southeast Asia. The Health Ministry stated that people included in the public worker ...
February 16, 2021
Vancouver, British Columbia--(Newsfile Corp. - February 16, 2021) - Tracesafe Inc. (CSE: TSF) ("TraceSafe"), a global leader in wearable safety tech and connected workforce solutions, including large-scale